NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 23,850
-600 (-2.45%)
Jan 19, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 277.53 billion as of January 16, 2026.
Market Cap
277.53B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
23,850.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 277.53B, an increase of 19.13%. That is a compound annual growth rate of 44.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 284.51B | 9.89% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |